Special Issue

Transplantation in Cancer Treatment

Submission Deadline: January 31, 2026 (Open) Submit Now

Guest Editors

Francesco Gaudio, MD

Professor, Department of Medicine and Surgery, LUM University, Casamassima, Bari, Italy

Website | E-Mail

Research Interests: Lymphoma; stem cell transplantation; bone marrow transplantation; hematologic diseases; hematopathology; chemotherapy

Stefano Martinotti, MD

Professor of Clinical Pathology, Department of Medicine and Surgery, LUM University, Casamassima, Bari, Italy

Website | E-Mail

Research Interests: Cancer genetics; cell culture; cytokines; signal transduction; cancer biology; molecular biology

Riccardo Memeo, MD, PhD

Professor of Surgery, Department of Medicine and Surgery, LUM University, Casamassima, Bari, Italy

Website | E-Mail

Research Interests: Laparoscopic surgery; oncology; minimally invasive surgery; abdominal surgery; general surgery; surgical oncology; gastrointestinal diseases; hernia surgery; hepatocellular carcinoma

About This Topic

This special issue aims to explore the evolving role of transplantation in the treatment of cancer, focusing on both hematologic malignancies and solid tumors. Transplantation therapies, including hematopoietic stem cell transplantation (HSCT) and organ transplantation, are crucial components of modern cancer treatment regimens, offering patients the potential for long-term remission and survival. The significance of this issue lies in the growing body of evidence supporting the integration of transplantation approaches with novel cancer therapies, such as immunotherapy and targeted treatments. This issue will feature contributions that address the latest advancements, challenges, and clinical outcomes related to transplantation in oncology. Topics may include but are not limited to, pre-transplant conditioning regimens, immune modulation, complications, and the integration of personalized medicine. We invite authors to contribute their research, clinical insights, and reviews on how transplantation continues to shape cancer care and how emerging technologies may further enhance patient outcomes.

Keywords

Hematopoietic stem cell transplantation; cancer treatment; immunotherapy; organ transplantation; cancer remission; transplantation complications; clinical outcomes; oncological stem cell therapies

Manuscript Submission Information

Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (transplantation@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.

Welcome your submission!